Inmune Bio, Inc. — Director's Dealing 2019

Sep 13, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inmune Bio, Inc. (INMB)
CIK: 0001711754
Period of Report: 2019-09-11

Reporting Person: Lowdell Mark William (Chief Scientific Officer, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-09-11	Common Stock	P	2918	$6.2298	Acquired	1506251	Direct

Footnotes

F1: The Reporting Person purchased an aggregate of 2,918 shares of the Registrant's common stock on September 11, 2019 in an open market transaction.